Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nemazee

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)|June 17, 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Science (New York, N.Y.)|June 17, 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Science Translational Medicine|September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concernHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variantsHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)|June 17, 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Science (New York, N.Y.)|June 17, 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Science Translational Medicine|September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concernHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variantsHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Pageof 13